Microdevices for Non-Invasive Detection of Bladder Cancer
Open Access
- 19 November 2017
- journal article
- review article
- Published by MDPI AG in Chemosensors
- Vol. 5 (4) , 30
Abstract
Bladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging as an important approach to contribute to initial diagnosis and follow-up, by enabling the precise manipulation of biological samples. Specifically, microdevices have been used for the isolation of cells or genetic material from blood samples, sparking significant interest as a versatile platform for non-invasive bladder cancer detection with voided urine. In this review, we revisit the methods of bladder cancer detection and describe various types of markers currently used for evaluation. We detail cutting-edge technologies and evaluate their merits in the detection, screening, and diagnosis of bladder cancer. Advantages of microscale devices over standard methods of detection, as well as their limitations, are provided. We conclude with a discussion of criteria for guiding microdevice development that could deepen our understanding of prognoses at the level of individual patients and the underlying biology of bladder cancer development. Collectively, the development and widespread application of improved microfluidic devices for bladder cancer could drive treatment breakthroughs and establish widespread, tangible outcomes on patients’ long-term survival.Keywords
This publication has 136 references indexed in Scilit:
- Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker TestsMolecular Diagnosis & Therapy, 2013
- Classification, Functions, and Clinical Relevance of Extracellular VesiclesPharmacological Reviews, 2012
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine SedimentsCancer Epidemiology, Biomarkers & Prevention, 2011
- Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinomaProteome Science, 2011
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chipProceedings of the National Academy of Sciences, 2010
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- The present and future burden of urinary bladder cancer in the worldWorld Journal of Urology, 2009
- A new approach to primer design for the control of PCR bias in methylation studiesBMC Research Notes, 2008
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005